Cytogenix (fka CYGX)

[hogger]

It indeed has the potential to be emormous ... it is also in a market that should experience rapid growth as the DNA based therapies become developed and accepted.

Let us hope and pray that this is not another bee in a bonnett that gets management fired up to a degree that everyone (as Confusedus would say) gets up each morning, mounts eight horses and rides off in all directions simultaneously.

Given the 'expertise' in the front office, one must wonder if this is the time to readjust the configuration of the management chart. Maybe we could see CYGX have two divisions headed by experienced 'hands-on' people. That way, each of these 'paradigm shifts" could get in gear and we could finally roar away from the starting line.